Writing Multiple Marketing Applications Simultaneously With Accelerated Timelines
A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s Marketing Authorization Application (MAA), New Drug Application (NDA), and New Drug Submission (NDS).
Learn how our medical writing team worked closely with the sponsors to write these marketing applications in an accelerated timeline since the product received Orphan Drug Designation in the United States and Europe and Priority Review status in Canada.
VIEW THE CASE STUDY! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.
Subscribe to Hydrocarbon Online X
Subscribe to Hydrocarbon Online